SNBNCBS introduced a No-touch & Painless device for non-invasive screening of bilirubin level expanding Jaundice meter market

 

Jaundice Meter Market

As per the regional assessment, North America is forecast to dominate the global Jaundice meter market in the near future. This is owing to the high spending on the healthcare sector coupled with the rapid adoption of the advanced diagnostic device. According to the U.S. Centers for Medicare & Medicaid Services, the National health spending is projected to grow at an average annual rate of 5.4 percent for 2019-28 and to reach $6.2 trillion by 2028.

There are a high prevalence and incidence of jaundice around the globe. This is creating demand for the jaundice monitoring device, thereby fueling the growth of the Jaundice meter. According to The Regents of The University of California, Jaundice is a common condition in newborns, affecting 50 percent to 60 percent of full-term babies and 80 percent of those born prematurely. It can give babies' skin and the whites of their eyes a yellowish tint. Moreover, advancement in the jaundice monitoring device is again supporting the growth of the Jaundice Meter market. For instance, in July 2020, SNBNCBS develops a No-touch & Painless device for non-invasive screening of bilirubin level in new-born.

A Jaundice meter is a device that measures the level of jaundice in blood. This disease is one of the many diseases that can cause harm to one's health as it is also known as "Jaundice" and is characterized by the yellowing or discoloration of one's skin, eyes, and other parts of the body. The disease can also cause damage to the kidneys and other organs of the human body. The main symptoms of jaundice include an itching sensation or a burning sensation upon urination. The person may also suffer from nausea, vomiting, fatigue, weight loss, muscle weakness, joint pains, and problems with the eyes. In some cases, the person suffering from jaundice may experience a yellow discoloration on the skin which can be detected through the measurement of serum albumin levels.

Key Developments:

1.      In September 2020, Konica Minolta, Inc. has partnered with the University of California, San Francisco (UCSF) Benioff Children’s Hospitals to support an initiative helping newborns in response to the COVID-19 crisis. The motive of this partnership is to provide a handheld transcutaneous bilirubin*1 meter to UCSF Newborn Telemedicine Program enabling remote newborn jaundice*2 assessment and management

2.      In July 2020, Scientists at the SN Bose National Centre for Basic Sciences, Kolkata, have developed non-contact and non-invasive spectrometry-based techniques for the measurement of bilirubin level in newborns to screen for signs of jaundice


Comments

Popular posts from this blog

Fitness Equipment Market is doing warm-ups to pull growth-rich opportunities from the growing obesity rates accompanied by the sedentary lifestyles

The market for ureteral stents would benefit from the rising prevalence of urological diseases

Increased Prevalence of Chronic Diseases and Stem Cell Therapy R&D to Drive Stem Cell Assay Market Growth